Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes? (Q41700902)

7 October 2017

1 reference

title

Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes? (English)

1 reference

7 October 2017

Wiesenfeld-Hallin Z

1

1 reference

7 October 2017

1 January 1998

1 reference

7 October 2017

1 reference

7 October 2017

55

1 reference

7 October 2017

1

1 reference

7 October 2017

1-4

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199855010-00001

7 October 2017

0 references

cites work

Dextromethorphan and neuromodulation: old drug coughs up new activities

1 reference

12 December 2020

Ketamine: its mechanism(s) of action and unusual clinical uses.

1 reference

12 December 2020

Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614

1 reference

12 December 2020

The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn

1 reference

12 December 2020

The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man.

1 reference

12 December 2020

Subcutaneous ketamine analgesia: postoperative analgesia using subcutaneous infusions of ketamine and morphine

1 reference

12 December 2020

Dextromethorphan attenuates and reverses analgesic tolerance to morphine

1 reference

12 December 2020

Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide

1 reference

12 December 2020

Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats

1 reference

12 December 2020

The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat

1 reference

12 December 2020

Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists.

1 reference

12 December 2020

Postoperative analgesia with ketamine and pethidine

1 reference

12 December 2020

Ketamine attenuates and reverses morphine tolerance in rodents.

1 reference

12 December 2020

Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy

1 reference

12 December 2020

The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids

1 reference

12 December 2020

Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain

1 reference

12 December 2020

Comparison of morphine and morphine with ketamine for postoperative analgesia

1 reference

12 December 2020

Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design

1 reference

12 December 2020

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

1 reference

12 December 2020

The effects of methionine- and leucine-enkephalin on spinal neurones of the cat

1 reference

12 December 2020

Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat

1 reference

12 December 2020

Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions.

1 reference

12 December 2020

Combined infusions of morphine and ketamine for postoperative pain in elderly patients.

1 reference

12 December 2020

The pharmacology of pain signalling

1 reference

12 December 2020

Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid

1 reference

12 December 2020

N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat

1 reference

12 December 2020

MK-801 blocks the expression but not the development of tolerance to morphine in the isolated spinal cord of the neonatal rat

1 reference

12 December 2020

Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan

1 reference

12 December 2020

Modulation of NMDA-induced currents by μ-opioid receptor agonist DAGO in acutely isolated rat spinal dorsal horn neurons

1 reference

12 December 2020

Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats

1 reference

12 December 2020

Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy

1 reference

12 December 2020

The induction and maintenance of central sensitization is dependent on N -methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states

1 reference

12 December 2020

10.2165/00003495-199855010-00001

Identifiers

DOI

1 reference

PubMed ID

9463786

Dimensions Publication ID

7 October 2017

0 references

1 reference

PubMed ID

9463786